Plague, an infectious disease that reached catastrophic proportions during three pandemics, continues to be a legitimate public health concern worldwide. Although antibiotic therapy for the causative agent Yersinia pestis is available, pharmaceutical supply limitations, multi-drug resistance from natural selection as well as malicious bioengineering are a reality. Consequently, plague vaccinology is a priority for biodefense research. Development of a multi-subunit vaccine with Fraction 1 and LcrV as protective antigens seems to be receiving the most attention. However, LcrV has been shown to cause immune suppression and Y. pestis mutants lacking F1 expression are thought to be fully virulent in nature and in animal experiments. The LcrV variant, rV10, retains the well documented protective antigenic properties of LcrV but with diminished inhibitory effects on the immune system. More research is required to examine the molecular mechanisms of vaccine protection afforded by surface protein antigens and to decipher the host mechanisms responsible for vaccine success.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achtman, M., Zurth, K., Morelli, G., Torrea, G., Guiyoule, A. and Carniel, E. (1999) Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. USA 96, 14043-14048.
Anderson, G.W., Jr., Leary, S.E.C., Williamson, E.D., Titball, R.C., Welkos, S.C., Worsham, P.L. and Friedlander, A.M. (1996) Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis. Infect. Immun. 64, 4580-4585.
Andrews, G.P., Heath, D.G., Anderson, G.W, Jr., Welkos, S.L and Friedlander, A.M. (1996) Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Es-cherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Im-mun. 64, 2180-2187.
Andrews, G.P., Strachan, S.T., Benner, G.E., Sample, A.K., Anderson, G.W. Jr., Adamovicz, J.J., Welkos, S.L., Pullen, J.K. and Friedlander, A.M. (1999) Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect. Immun. 67, 1533-1537.
Baker, E.E., Somer, H., Foster, L.W., Meyer, E. and Meyer, K.F. (1952) Studies on immuniza-tion against plague. I. The isolation and characterization of the soluble antigen of Pas-teurella pestis. J. Immunol. 68, 131-145.
Benner, G.E., Andrews, G.P., Byrne, W.R., Strachan, S.D., Sample, A.K., Heath, D.G. and Friedlander, A.M. (1999) Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental infection in mice. Infect. Immun. 67, 1922-1928.
Boyd, A.P., Grosdent, N., Totemeyer, S., Geuijen, C., Bleves, S., Iriarte, M., Lambermont, I., Octave, J-N. and Cornelis, G.R. (2000) Yersinia enterocolitica can deliver Yop proteins into a wide range of cell types, development of a delivery system for heterologous pro-teins. Eur. J. Cell Biol. 79, 659-671.
Brubaker, R. R. (2003) Interleukin-10 and the inhibition of innate immunity to yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71, 3673-3681.
Brubaker, R.R. (1969) Mutation rate to nonpigmentation in Pasteurella pestis. Journal of bacteriology. 98(3), 1404-1406.
Burrows, T.W. (1957) Virulence of Pasteurella pestis. Nature 179, 1246-1247.
Burrows, T. W. (1963) Virulence of Pasteurella pestis and immunity to plague. Ergebn. Mik-robiol. 37, 59-113.
Burrows, T.W. and Bacon, G.A. (1956) The basis of virulence in Pasteurella pestis, antigen determining virulence. Br. J. Exp. Pathol. 37, 481-493.
Burrows, T.W. and Bacon, G.A. (1958) The effect of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Br. J. Exp. Pathol. 39, 278-291.
Cornelis, G. R. (1998) The Yersinia deadly kiss. J. Bacteriol. 180, 5495-5504.
Cornelis, G.R., Boland, A., Boyd, A.P., Geuijen, C., Iriarte, M., Neyt, C., Sory, M.-P and Stainier, I. (1998) The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62, 1315-1352.
Crook, L.D. and Tempest, B. (1992) Plague, a clinical review of 27 cases. Arch. Intern. Med. 152, 1253-1256.
Davis, K.J., Fritz, D.L., Pitt, M.L.M., Welkos, S.L., Worsham, P.L. and Friedlander, A.M. (1996) Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopitheus aethiops). Arch. Pathol. Lab. Med. 120,156-163.
DeBord K.L., Anderson, D.M., Marketon, M.M., Overheim, K.A., DePaolo, R.W., Ciletti, N.A, Jabri, B. and Schneewind, O. (2006) Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. Infect Immun. 74, 4910-4914.
Deng, W., Burland, V., Plunkett, G.R., Boutin, A., Mayhew, G.F., Liss, P., Perna, N.T., Rose, D.J., Mau, B., Zhou, S., Schwartz, D.C., Fetherston, J.D., Lindler, L.E., Brubaker, R.R., Plano, G.V., Straley, S.C., McDonough, K.A., Nilles, M.L., Matson, J.S., Blattner, F.R. and Perry, R.D. (2002) Genome sequence of Yersinia pestis KIM. J. Bacteriol. 184, 4601-4611.
Eyles, J.E., Williamson, E.D., Spiers, I.D. and Alpar, H.O. (2000) Protection studies following bronchopulmonary and intramuscular immunization with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres, a comparison of efficacy. Vaccine 18, 3266-3271.
Ferber, D.M. and Brubaker, R.R. (1981) Plasmids in Yersinia pestis. Infect. Immun. 31, 839-841.
Friedlander, A.M., Welkos, S.L., Worsham, P.L., Andrews, G.P., Heath, D.G., Anderson, G.W., Pitt, M.L.M., Estep, J. and Davis, K. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin. Infect. Dis. 21(Suppl. 2), 178-181.
Galimand, M., Carniel, E. and Courvalin, P. (2006) Resistance of Yersinia pestis to antimicro-bial agents. Antimicrob Agents Chemother. 50, 3233-3236
Galimand, M., Guiyoule, A., Gerbaud, G., Rasoamanana, B., Chanteau, S., Carniel, E. and Courvalin, P. (1997) Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 337:677-680.
Haffkine, W.M. (1897) Remarks on the plague prophylactic fluid. Br. Med. J. 1, 1461.
Heath, D.G., Anderson, G.W., Jr., Mauro, J.M., Welkos, S.L., Andrews, G.P., Adamovicz, J.J. and Friedlander, A.M. (1998) Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine. 16, 1131-1137.
Hu, P., Elliott, J., McCready, P., Skowronski, E., Garnes, J., Kobayashi, A., Brubaker, R. and Garcia, E. (1998) Structural organization of virulence-associated plasmids of Yersinia pestis. J. Bacteriol. 180, 5192-5202.
Inglesby, T.V., Dennis, D.T., Henderson, D.A., Bartlett, J.G., Ascher, M.S., Eitzen, E., Fine, A.D., Friedlander, A.M., Hauer, J., Koerner, J.F., Layton, M., McDade, J., Osterholm, M.T., O’Toole, T., Parker, G., Perl, T.M., Russell, P.K., Schoch-Spana, M. and Tonat, K. (2000) Plague as a biological weapon, medical and public health management. JAMA 283, 2281-2290.
Jones, S.M., Day, F., Stagg, A.J. and Williamson, E.D. (2001) Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine. 19, 358-366.
Lawto, W.D., Erdman, R.L. and Surgalla, M.J. (1963) Biosynthesis and purification of V and W antigen in Pasteurella pestis. J. Immunol. 91, 179-184.
Marketon, M.M., DePaolo, R.W., DeBord, K.L., Jabri, B. and Schneewind, O. (2005) Plague bacteria target immune cells during infection. Science. 309, 1739-1741.
Meyer, K. (1961) Pneumonic plague. Bacteriol. Rev. 25, 249-261.
Meyer, K., Cavanaugh, D.C., Bartelloni, P.J. and Marshall, J.D. Jr. (1974) Plague Immuniza-tion I. Past and Present Trends. J. Infect. Dis. 129, S13-S18.
Meyer, K.F., Hightower, J.A. and McCrumb, F.R. (1974) Plague immunization. VI. Vaccina-tion with the fraction 1 antigen of Yersinia pestis. J. Infect. Dis. 129, S41-S45.
Michiels, T., Wattiau, P., Brasseur, R., Ruysschaert, J.-M and Cornelis, G. (1990) Secretion of Yop proteins by yersiniae. Infect. Immun. 58, 2840-2849.
Motin, V.L., Nedialkov, Y.A. and Brubaker, R.R. (1994) Passive immunity to yersiniae medi-ated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62, 3021-3029.
Nakajima, R., Motin, V.L. and Brubaker, R.R. (1993) Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 63, 3021-3029.
Nakajima, R., Motin, V.L. and Brubaker, R.R. (1995) Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63, 3021-3029.
Nedialkov, Y.A., Motin, V.L. and Brubaker, R.R. (1997) Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide, amplification of interleukin-10. Infect. Immun. 65, 1196-1203.
Overheim, K.A., Depaolo, R.W., Debord, K.L., Morrin, E.M., Anderson, D.M., Green, N.M., Brubaker, R.R., Jabri, B. and Schneewind, O. (2005) LcrV plague vaccine with altered immunomodulatory properties. Infect. Immun. 73, 5152-5159.
Parkhill, J., Wren, B.W., Thompson, N.R., Titball, R.W., Holden, M.T., Prentice, M.B., Â Sebaihia, M., James, K.D., Churcher, C., Mungall, K.L., Baker, S., Dasham, D., Bentley, S.D., Brokks, K.Cerdeno-Tarraga, A.M., Chillingworth, T., Cronin, A., Davies, R.M., Davis, P., Dougan, G., Feltwell, T., Hamlin, N., Holroyd, S., Jagels, K., Karlyshev, A.V., Leather, S., Moule, S., Oyston, P.C., Quail, M., Rutherford, K., Simmonds, M., Skelton, J., Stevens, K., Whitehead, S. and Barrell, B.G. (2001) Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413, 523-527.
Perry, R.D. and Fetherston, J.D. (1997) Yersinia pestis - etiologic agent of plague. Clin. Microbiol. Rev. 10, 35-66.
Philipovskiy, A.V., Cowan, C.R., Wulff-Strobel, S.H., Burnett, S.H., Kerschen, E.J., Cohen, D.A., Kaplan, A.M. and Straley, S.C. (2005) Antibody against V antigen prevents Yopdependent growth of Yersinia pestis. Infect. Immun. 73, 1532-1542.
Prior J.L., Hitchen P.G., Williamson D.E., Reason A.J., Morris H.R., Dell A., Wren B.W., Titball R.W. (2001) Characterization of the lipopolysaccharide of Yersinia pestis. Microb. Pathog. 30, 49-57.
Russell, P., Eley, S.M., Hibbs, S.E., Manchee, R.J., Stagg, A.J. and Titball, R.W. (1995) A comparison of Plague Vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model, Vaccine. 13, 1551-1556.
Sing, A., Roggenkamp, A., Geiger, A.M. and Heesemann, J. (2002) Yersinia enterocolitica evasion of the host immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168, 1315-1321.
Sing, A., Rost, D., Tvardovaskaia, N., Roggenkamp, A., Wiedemann, A., Kirschning, C., Aepfelbacher, J.M. and Heesemann, J. (2002) Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196, 1017-1024.
Skurnik, M., Peippo, A. and Ervela, E. (2000) Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1b. Mol. Microbiol. 37, 316-330.
Taylor, V.L., Titball, R.W. and Oyston, P.C.F. (2005) Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiol. 151, 1919-1926.
Titball, R.W. and Williamson, E.D. (2001) Vaccination against bubonic and pneumonic plague. Vaccine. 19, 4175-4184.
Une, T. and Brubaker, R.R. (1984) Role of V antigen in promoting virulence and immunity in yersiniae. J. Immunol. 133, 2226-2230.
Weeks, S., Hill, J., Friedlander, A. and Welkos, A. (2002) Anti-V antigen antibody protects madcrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb. Pathog. 32, 227-237.
(2006) Wkly. Epidemiol. Rec. 81, 278-84.
Williamson, E.D (2001) Plague vaccine research and development. J. Appl. Microbiol. 91, 606-608.
Williamson, E.D., Eley, S.M., Stagg, A.J., Green, M., Russell, P. and Titball, R.W. (2000) A single dose sub-unit vaccine protects against pneumonic plague. Vaccine. 19, 566-571.
Williamson, E.D., Eley, S.M., Stagg, A.J., Green, M., Russell, P. and Titball, R.W. (1997) A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine. 15, 1079-1084.
Winter, C.C., Cherry, W.B. and Moody, M.D. (1960) An unusual strain of Pasteurella pestis isolated from a fatal case of human plague. Bull. W.H.O. 23, 408-409.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cornelius, C., Schneewind, O., Anderson, D., Quenee, L. (2007). Protective Immunity Against Plague. In: Perry, R.D., Fetherston, J.D. (eds) The Genus Yersinia. Advances In Experimental Medicine And Biology, vol 603. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72124-8_38
Download citation
DOI: https://doi.org/10.1007/978-0-387-72124-8_38
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72123-1
Online ISBN: 978-0-387-72124-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)